Classical cardiovascular risk factors according to fasting plasma glucose levels

European Journal of Internal Medicine

Volumn 19, Issue 3, 2008, Pages 209-213

  Martinez Hervas, Sergio ^a   Romero, Pedro ^b   Hevilla, Enrique B ^c   Real, José T ^a   Priego, Antonia ^a   Martin Moreno, Jose M ^c   Carmena, Rafael ^a   Ascaso, Juan F ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b Onda Primary Care Center   (Spain)

^c UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Cardiovascular risk factors; Impaired fasting glucose; Metabolic syndrome

Indexed keywords

APOLIPOPROTEIN B; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; INSULIN RESISTANCE; LOGISTIC REGRESSION ANALYSIS; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE;

ADULT; AGED; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; COMORBIDITY; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SPAIN;

EID: 41349085782     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2007.09.005     Document Type: Article

References (27)

1. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 1 (2004) S15-S35 Suppl
2. Sattar N., Williams K., Sniderman A.D., D'Agostino R., and Haffner S.M. Non-high-density lipoprotein cholesterol with other cardiovascular risk factors in patients with the metabolic syndrome in the insulin resistance atherosclerosis study. Circulation 110 (2004) 2687-2693
3. Despres J.P., Lamarche B., Mauriege P., Cantin B., Dagenais G.R., Moorjani S., et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N. Engl. J. Med. 334 (1996) 952-957
4. McGarry J.D. What if Minkowski had been ageusic? An alternative angle on diabetes. Science 258 (1992) 766-774
5. Ascaso J.F., Romero P., Real J.T., Lorente R.I., Martínez-Valls J., and Carmena R. Abdominal adiposity (waist circumference) and its relation to insulin resistance and the metabolic syndrome in a South European Population. Eur. J. Intern. Med. 14 (2003) 101-106
6. Allain C.C., Poon L.S., Chan C.S.G., Richmod W., and Fu P.C. Enzymatic determination of total serum cholesterol. Clin. Chem. 20 (1979) 470-475
7. Ter H.F., Baarscheer T., and Fiolet J.W.T. Influence of free glycerol on enzymatic of triglycerides. Clin. Chem. 30 (1984) 1102-1103
8. Rosseneau M., Verchemst R., Steinberg K.K., and Cooper G.R. Some considerations of methodology and standardization of apolipoprotein B immunoassays. Clin. Chem. 29 (1983) 427-433
9. Trinder P. Enzymatic colorimetric method for glucose determination. Ann. Clin. Biochem. 6 (1969) 24-27
10. Berson S., and Yellow R.S. Quantitative aspects of the reaction between insulin and insulin-binding antibody. J. Clin. Invest. 38 (1959) 1996-2016
11. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Teacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and B cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 28 (1985) 412-419
12. Ascaso J.F., Romero P., Real J.T., Priego A., Valdecabres C., and Carmena R. nsulin resistance quantification by fasting insulin plasma values and HOMA index in a non-diabetic population. Med. Clin. (Barc) 117 (2001) 530-533
13. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 285 (2001) 2486-2497
14. Tamayo B., Faure E., Roche M.J., Rubio E., Sánchez E., and Salvador J.A. Prevalence of diabetes and impaired glucose tolerance in Aragon, Spain. Diabetes Care 20 (1977) 534-536
15. Diabetes Prevention Program Research Group. Strategies to identify adults at high risk for type 2 diabetes: the Diabetes Prevention Program. Diabetes Care 28 (2005) 138-144
16. de Pablos-Velasco P.L., Martínez-Martín F.J., Rodríguez-Pérez F., Anía B.J., Losada A., and Betancor P. Guia Study. Prevalence and determinants of diabetes mellitus and glucose intolerance in a Canarian Caucasian population-comparison of the 1997 ADA and the 1985 WHO criteria. The Guía Study. Diabet. Med. 3 (Mar 18 2001) 235-241
17. Heldgaard P.E., Olivarius N de F., Hindsberger C., and Henriksen J.E. Impaired fasting glycaemia resembles impaired glucose tolerance with regard to cardiovascular risk factors: population-based, cross-sectional study of risk factors for cardiovascular disease. Diabet. Med 21 (2004) 363-370
18. Bartnik M., Rydén L., Ferrari R., Malmberg K., Pyörälä K., Simoons M., et al. Euro Heart Survey Investigators. The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart. Eur. Heart J. 25 (2004) 1880-1890
19. Malik S., Wong N.D., Franklin S.S., Kamath T.V., L'Italien G.J., Pio J.R., et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 110 (2004) 1245-1250
20. Wang J., Ruotsalainen S., Moilanen L., Lepistö P., Laakso M., and Kuusisto J. The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns. Eur. Heart J. 28 (2007) 857-864
21. Kanaya A.M., Herrington D., Vittinghoff E., Lin F., Bittner V., Cauley J.A., et al. Impaired fasting glucose and cardiovascular outcomes in postmenopausal women with coronary artery disease. Ann. Intern. Med. 142 (2005) 813-820
22. Rijkelijkhuizen J.M., Nijpels G., Heine R.J., Bouter L.M., Stehouwer C.D.A., and Dekker J.M. High risk cardiovascular mortality in individuals with impaired fasting glucose is explained by conversion to diabetes. The Hoorn Study. Diabetes Care 30 (2007) 332-336
23. Forouhi N.G., Balkau B., Borch-Johnsen K., Dekker J., Glumer C., Qiao Q., et al. EDEG. The threshold for diagnosing impaired fasting glucose: a position statement by the European Diabetes Epidemiology Group. Diabetologia 49 (2006) 822-827
24. Haffner S.M., Gonzalez C., Miettinen H., Kennedy E., and Stern M.P. A prospective analysis of the HOMA model. The Mexico City Diabetes Study. Diabetes care 19 (1996) 1138-1141
25. Kashiwabara H., Inaba M., Maruno Y., Morita T., Awata T., Negishi K., et al. Insulin levels during fasting and the glucose tolerance test and HOMA's index predict subsequent development of hypertension. J. Hypertens. 18 (2000) 83-88
26. Solymoss B.C., Bourassa M.G., Campeau L., Sniderman A., Marcil M., Lesperance J., et al. Effect of increasing metabolic syndrome score on atherosclerotic risk profile and coronary artery disease angiographic severity. Am. J. Cardiol. 93 (2004) 159-164
27. Meigs J.B., Larson M.G., D'Agostino R.B., Levy D., Clouse M.E., Nathan D.M., et al. Coronary artery calcification in type 2 diabetes and insulin resistance. The Framingham Offspring Study. Diabetes Care 25 (2002) 1313-1319